StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | MDGL Madrigal Pharmaceuticals | $533.33 | -1.22% | — | — | — | — | — | 37 |
| 1 | NVO Novo Nordisk | $44.54 | -2.76% | — | — | — | — | — | 70 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $1003.13 |
| -0.34% |
| — |
| — |
| — |
| — |
| — |
| 64 |
| 3 | TEM Tempus AI | $43.88 | -3.58% | — | — | — | — | — | 63 |
| 4 | GILD Gilead Sciences | $129.41 | -2.01% | — | — | — | — | — | 62 |
| 5 | AMGN Amgen | $327.88 | -2.49% | — | — | — | — | — | 59 |
| 6 | MRNA Moderna | $48.37 | -3.32% | — | — | — | — | — | 58 |
| 7 | BNTX BioNTech | $89.03 | -3.22% | — | — | — | — | — | 57 |
| 8 | REGN Regeneron | $698.49 | -2.02% | — | — | — | — | — | 56 |
| 9 | VRTX Vertex Pharma | $441.24 | -2.04% | — | — | — | — | — | 49 |